Impact of the COVID-19 Pandemic on Global TAVR Activity
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2023.10.041 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Xavier Armario und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Galway University Hospital, Galway, Ireland; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays. OBJECTIVES: This study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity. METHODS: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses. RESULTS: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (-52%; P = 0.001), Central-South America (-33%; P < 0.001), and Asia (-29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity. CONCLUSIONS: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Galway University Hospital, Galway, Ireland; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Cardiology, Galway University Hospital, Galway, Ireland.
- School of Mathematical and Statistical Sciences, University of Galway, Galway, Ireland.
- Heart Center Leipzig, Leipzig, Germany.
- Heart and Diabetes Center Northrhine-Westfalia, Clinic for Thoracic and Cardiovascular Surgery, Bad Oeynhausen, Germany.
- Institut Cardiovasculaire Paris Sud, Massy, France.
Zitieren
APA
Armario, X., Carron, J., Simpkin, A. J., Elhadi, M., Kennedy, C., Abdel-Wahab, M., Bleiziffer, S., Lefèvre, T., Wolf, A., Pilgrim, T., Villablanca, P. A., Blackman, D. J., Van Mieghem, N. M., Hengstenberg, C., Swaans, M. J., Prendergast, B. D., Patterson, T., Barbanti, M., Webb, J. G., …, & Regueiro, A. (2024). Impact of the COVID-19 Pandemic on Global TAVR Activity. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2023.10.041
Vancouver
Armario X, Carron J, Simpkin AJ, Elhadi M, Kennedy C, Abdel-Wahab M, et al. Impact of the COVID-19 Pandemic on Global TAVR Activity. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2023.10.041
BibTeX
@article{Armario2024,
author = {Armario, Xavier and Carron, Jennifer and Simpkin, Andrew J and Elhadi, Mohamed and Kennedy, Ciara and Abdel-Wahab, Mohamed and Bleiziffer, Sabine and Lefèvre, Thierry and Wolf, Alexander and Pilgrim, Thomas and Villablanca, Pedro A and Blackman, Daniel J and Van Mieghem, Nicolas M and Hengstenberg, Christian and Swaans, Martin J and Prendergast, Bernard D and Patterson, Tiffany and Barbanti, Marco and Webb, John G and Behan, Miles and Resar, Jon and Chen, Mao and Hildick-Smith, David and Spence, Mark S and Zweiker, David and Bagur, Rodrigo and Teles, Rui and Ribichini, Flavio L and Jagielak, Dariusz and Park, Duk-Woo and Kornowski, Ran and Wykrzykowska, Joanna J and Bunc, Matjaz and Estévez-Loureiro, Rodrigo and Poon, Karl and Götberg, Matthias and Jeger, Raban V and Ince, Hüseyin and Packer, Erik J S and Angelillis, Marco and Nombela-Franco, Luis and Guo, Yingqiang and Savontaus, Mikko and Al-Moghairi, Abdulrahman M and Parasca, Catalina Andreea and Kliger, Chad and Roy, David and Molnár, Levente and Silva, Mariana and White, Jonathon and Yamamoto, Masanori and Carrilho-Ferreira, Pedro and Toggweiler, Stefan and Voudris, Vassileios and Ohno, Yohei and Rodrigues, Inês and Parma, Radosław and Ojeda, Soledad and Toutouzas, Kostas and Regueiro, Ander},
title = {Impact of the COVID-19 Pandemic on Global TAVR Activity},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2023.10.041}
}
EUVIMED